Neuralink dementia research

How are investors and the biotech community reacting to claims about an Elon Musk Alzheimer’s cure?

Investors are showing renewed appetite for the —partly fueled by ’s high-profile efforts and wider neuro-AI optimism—but they remain cautious about clinical risk and historical failures in Alzheimer’s...